Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Analysis of protein and miRNA cargo of human conjunctival extracellular vesicles
Author Affiliations & Notes
  • Laura Garcia-Posadas
    IOBA, Universidad de Valladolid, Valladolid, Castilla y León, Spain
  • Ismael Romero-Castillo
    IOBA, Universidad de Valladolid, Valladolid, Castilla y León, Spain
  • Yolanda Diebold
    IOBA, Universidad de Valladolid, Valladolid, Castilla y León, Spain
    Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
  • Footnotes
    Commercial Relationships   Laura Garcia-Posadas None; Ismael Romero-Castillo None; Yolanda Diebold None
  • Footnotes
    Support  Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) Grants RTI2018–094071-B-C21 and PDC2022-133239-C21
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3633. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Garcia-Posadas, Ismael Romero-Castillo, Yolanda Diebold; Analysis of protein and miRNA cargo of human conjunctival extracellular vesicles. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3633.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Extracellular vesicles (EVs) are membranous structures released by cells. EVs carry a cargo of proteins, nucleic acids, and lipids that can mediate different biological functions. The purpose of this study is to characterize the protein and miRNA cargo of EVs isolated from human conjunctival epithelial and stromal cells.

Methods : This study followed all ethical requirements. Three different human cell types were used: the immortalized human conjunctival epithelial cell line IM-HConEpiC, conjunctival mesenchymal stromal cells (Conj-MSCs) isolated from cadaveric donor tissue, and adipose tissue (AT)-MSCs obtained from lipoaspirates. EVs were isolated from cell culture conditioned media by differential ultracentrifugation. EV morphology was evaluated by atomic force microscopy (AFM) and size was determined by dynamic light scattering (DLS). EVs were characterized for CD9 and CD63 marker expression and quantified with the ExoELISA-Step kit (Immunostep). Protein cargo of EVs was analyzed by mass spectrometry using untargeted LC–MS/MSshotgun approach in TimsTOF Pro (Bruker). Micro RNAs (miRNA) were purified from EV samples and analyzed by Next Generation Sequencing (NGS). Three different samples from each cell type were studied.

Results : EVs isolated from the three human cell types had round morphology observed by AFM, and co-expressed CD9 and CD63 markers. DLS analysis showed mean sizes of 330.1 ± 63.1 nm for IM-ConEpiC-EVs, 230.0 ± 37.0 nm for Conj-MSC-EVs, and 196.4 ± 28.6 nm for AT-MSC-EVs. Mass spectrometry revealed the presence of 1,892 proteins in the analyzed EVs. From them, 918 were found in the 3 cell types, whereas 300 were exclusively found in IM-HConEpiC-EVs, 19 in Conj-MSC-EVs, and 40 in AT-MSC-EVs. 1,111 mature miRNAs were detected in the EVs by NGS analysis. 312 miRNAS were present in the three cell type EVs, whereas 365 miRNAs were exclusively detected in IM-HConEpiC-EVs, 89 in Conj-MSC-EVs, and 87 in AT-MSC-EVs. Detected proteins and miRNAs are mainly involved in signal transduction, cell communication, metabolism, and cell growth.

Conclusions : We carried out the first exhaustive analysis of conjunctival EVs cargo. Conjunctival epithelial cell derived EVs contain more proteins and miRNAs than stromal ones. Conj-MSC-EVs and AT-MSC-EVs share many characteristics that could imply that Conj-MSC-EVs might also have important therapeutic properties.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×